Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000872262 | SCV001014051 | likely benign | not provided | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002454018 | SCV002737603 | likely benign | Hereditary cancer-predisposing syndrome | 2019-10-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002507520 | SCV002808323 | likely benign | Patterned macular dystrophy 2 | 2022-05-16 | criteria provided, single submitter | clinical testing |